Medicine

Erin Waters

Erin Waters

Shiv Thanigaimani

Shiv Thanigaimani

Alkira Deren

Alkira Deren

Michael Robinson

Michael Robinson

Nalita Turner

Nalita Turner

Bunmi Malau-Aduli

Bunmi Malau-Aduli

Jenna Graffini

Jenna Graffini

Mel Muscat

Mel Muscat

Yvonne Hornby-Turner

Yvonne Hornby-Turner

Geoffrey Dobson

Geoffrey Dobson

Mental Health Collaborative Evaluation Project
Karen Carlisle
01 Apr 2018 - 31 Dec 2019
Western Queensland PHN is one of 31 PHNs established to improve the efficiency and effectiveness of primary care services for patients, particularly those at risk of poor health outcomes. The mental health collaborative is part of the wider Australian Primary Care Collaborative (APCC) program which is a key part of the Australian General Practice quality improvement landscape. The mental health collaborative aims to encourage practices to engage in a continuous quality improvement (CQI) approach to improve mental health care provided and health outcomes. The program provides support to general practices and other primary health care services to deliver rapid, measurable, systematic and sustainable improvements in the care they provide to patients. The purpose of this evaluation is to determine the association of implementation of the mental health collaborative with changes in client outcomes (particularly overall wellbeing and functioning) over a 12 month period.
Identification of good practices in engaging communities in research for implementation and in social innovation in health in low- and middle-income countries
Karen Carlisle
01 Apr 2021 - 31 Dec 2021
This project will undertake a systematic review to identify lessons learned around processes to engage communities in health services research in low and middle countries in South East Asia and the Pacific. It will focus on both the types of engagement (participants, stakeholders, partners, initiators and leaders) and the results update processes and outcomes. It will adhere to the Preferred Reporting Items for Systematic Reviews and Meta- Analysis (PRISMA) checklist and access published, systematic reviews and grey literature.
Are Australians in midlife ready to implement Lifestyle Medicine to improve their health and wellbeing?
Sam Manger
01 Jan 2025 - 31 Dec 2025
The global population is ageing and with an ageing population comes an increase in the prevalence of non-communicable diseases. An opportune life stage to reduce the burden of non-communicable diseases in older age is midlife. Addressing these health issues at this midlife stage can help with the transition into a healthier older age. Lifestyle Medicine (LM) can be used as a method of managing overall health and wellbeing as well as preventing chronic disease. Despite what is known about the increase in chronic diseases and the high potential of LM, LM is still not utilised enough in healthcare. This student led project aims to understand what Australians in midlife know about Lifestyle Medicine (LM) and examine attitudes towards using LM to improve health and wellbeing. This research will add to the knowledge of acceptance of LM in midlife, to inform future health interventions.
Are Australians in midlife ready to implement Lifestyle Medicine to improve their health and wellbeing?
Karen Carlisle
01 Jan 2025 - 31 Dec 2025
The global population is ageing and with an ageing population comes an increase in the prevalence of non-communicable diseases. An opportune life stage to reduce the burden of non-communicable diseases in older age is midlife. Addressing these health issues at this midlife stage can help with the transition into a healthier older age. Lifestyle Medicine (LM) can be used as a method of managing overall health and wellbeing as well as preventing chronic disease. Despite what is known about the increase in chronic diseases and the high potential of LM, LM is still not utilised enough in healthcare. This student led project aims to understand what Australians in midlife know about Lifestyle Medicine (LM) and examine attitudes towards using LM to improve health and wellbeing. This research will add to the knowledge of acceptance of LM in midlife, to inform future health interventions.
A pilot trial of combined hyperbaric oxygen therapy (HBOT) and a Lifestyle Medicine (LM) program for multimorbid conditions
Sam Manger
05 May 2025 - 27 Jun 2025
Lifestyle Medicine is a rapidly emerging modality of treatment to optimise chronic disease management and prevention. Its application is underutilised in primary and tertiary healthcare with research showing low risk and great benefit with this non-conventional approach. Lifestyle medicine incorporates 6 pillars of health and wellbeing, including nutrition, physical activity, minimising stress, enhancing sleep, addressing addictive behaviours and maintaining community connectedness. Patients at the Department of Diving and Hyperbaric Medicine (DDHM) have treatment plans that are daily Hyperbaric Oxygen Therapy (HBOT) sessions undertaken in a compression chamber. The daily treatments can extended upwards of 4-8 weeks. The majority of patients have 2 or more chronic conditions (multimorbidity) and take 5 or more medications (polypharmacy). Multimorbidity and polypharmacy are known to increase non-adherence to medical advice, risk of side effects, cost to the patient and health system, and shorten quality and quantity of life. Lifestyle Medicine reduces severity of chronic disease and supports health and wellbeing, thereby reducing the overall burden of illness and its impact on the person and healthcare services. The DDHM provides the perfect opportunity for a patient-centred LM approach that can be attached to standard care with minimal interruption to services, staff, patients, or budget, with provision of a template that can be adapted to meet acceptability and feasibility feedback from participants and staff. The LM program supports the overaching goals of HBOT integration by supplementing a siloed approach to health provision with a LM group based program during standard patient care in the DDHM. This program will ideally enhance patient health, wellbeing and service satisfaction, plus support staff satisfaction through their involvement with provision of holistic health care.
A pilot trial of combined hyperbaric oxygen therapy (HBOT) and a Lifestyle Medicine (LM) program for multimorbid conditions
Sam Manger
05 May 2025 - 27 Jun 2025
Lifestyle Medicine is a rapidly emerging modality of treatment to optimise chronic disease management and prevention. Its application is underutilised in primary and tertiary healthcare with research showing low risk and great benefit with this non-conventional approach. Lifestyle medicine incorporates 6 pillars of health and wellbeing, including nutrition, physical activity, minimising stress, enhancing sleep, addressing addictive behaviours and maintaining community connectedness. Patients at the Department of Diving and Hyperbaric Medicine (DDHM) have treatment plans that are daily Hyperbaric Oxygen Therapy (HBOT) sessions undertaken in a compression chamber. The daily treatments can extended upwards of 4-8 weeks. The majority of patients have 2 or more chronic conditions (multimorbidity) and take 5 or more medications (polypharmacy). Multimorbidity and polypharmacy are known to increase non-adherence to medical advice, risk of side effects, cost to the patient and health system, and shorten quality and quantity of life. Lifestyle Medicine reduces severity of chronic disease and supports health and wellbeing, thereby reducing the overall burden of illness and its impact on the person and healthcare services. The DDHM provides the perfect opportunity for a patient-centred LM approach that can be attached to standard care with minimal interruption to services, staff, patients, or budget, with provision of a template that can be adapted to meet acceptability and feasibility feedback from participants and staff. The LM program supports the overaching goals of HBOT integration by supplementing a siloed approach to health provision with a LM group based program during standard patient care in the DDHM. This program will ideally enhance patient health, wellbeing and service satisfaction, plus support staff satisfaction through their involvement with provision of holistic health care.
Peer Work in Primary Care
Sam Manger
Exploring the implementation of a peer support workforce for mental health support in Australia Primary Care in rural and urban centres. This project brings together lived experience organisations, health services and health researchers to increase the capacity of primary care services to provide evidence-based preventive care for mental ill-health. Collaboratively, we have co-designed and are evaluating an evidence-based peer support intervention in the primary care setting in Australia
National Multidisciplinary Primary Care Research, Policy and Advocacy Consortium
Sam Manger
Led by Professor Michael Kidd (UNSW/Oxford and CMO of the Federal Government) members of the National Multidisciplinary Primary Care Research, Policy and Advocacy Consortium (“The Consortium”) will work collaboratively to support future-focused ways of thinking about primary care delivered through multidisciplinary team (MDT)-based care. The Consortium will generate, coordinate, and disseminate knowledge on innovative models of MDT-based primary care that improve health outcomes for people living in all parts of Australia. The Consortium brings together consumers and expert partners from across the country to identify where, when, and how MDT-based primary care can meaningfully address challenges facing our health care system. The Consortium will be a major national resource that supports ongoing federal, state and territory programs of primary care reform, strengthens the evidence base on primary care service delivery and outcomes, and accelerates the translation of knowledge into improvements in clinical care, while also increasing nationwide primary care clinician researcher capacity.
The Men’s Table Evaluation
Sam Manger
Funded by the Queensland Mental Health Commission (QMHC), our team is performing an independent evaluation of The Men's Table (TMT) program which has been funded by the QMHC to implemented 10 “tables” across urban and rural Queensland. TMT is a peer-led service that fosters social connections among men, offering a safe, non-judgmental environment to discuss feelings and life challenges
The Living-well Club (TLC) at Southport Low Acuity Service Hotel (SPLASH)
Sam Manger
The Living-well Club (TLC) at Southport Low Acuity Service Hotel (SPLASH) is a volunteer led social prescribing pilot to improve the biopsychosocial health of inpatients and staff. The pilot is being evaluated to address loneliness, health outcomes and satisfaction by providers and inpatients. The broader goal is to design an implementation framework that can be scaled to other low acuity facilities, such as aged care, community, and inpatient healthcare services.

Targets for medical therapy to limit abdominal aortic aneurysm progression

A Papua New Guinea - Australia HIV research partnership: generating new knowledge, building capacity and forging new friendships

Interpretive focus groups: a participatory method for interpreting and extending secondary analysis of qualitative data

Mouse models of intracranial aneurysm

Predictors of rural practice location for James Cook University MBBS graduates at postgraduate year 5

microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155

A deletion in chromosome 6q is associated with human abdominal aortic aneurysm

Workplace immersion in the final year of an undergraduate medicine course: the views of final year students and recent graduates

Association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease: a systematic review and meta-analysis

Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication

Title: Editorial board Arteriosclerosis, Thrombosis and Vascular Biology
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2012
Title: Editorial board member, Arteriosclerosis, Thrombosis and Vascular Biology
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2012
Title: Member of The Australian and International Stroke Genetics Collaboration
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2009
Title: Member of The Research Committee of the Faculty Medicine, Health and Molecular Sciences
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2009
Title: Member of the Board of Surgical Research of the Royal Australasian College of Surgeons
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2007
Title: Member of the Australian Vascular Biology Society
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2002
Title: Member of the School of Medicine Research Committee, James Cook University
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2002
Title: Member of the European Society of Vascular Surgery
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 1996
Title: Member of the ethics committee, The Mater Hospital, Townsville
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2002
End Date: 01 Jan 2009
Title: Member of the Biological Sciences selection panel for internal grants, James Cook University
Reseracher: Jonathan Golledge (Distinguished Professor)
Start Date: 01 Jan 2003
End Date: 01 Jan 2004